| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |